Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 12-2019 | |
| Operating Expenses | 5,612 | 3,008 | 0 | 18 | 0 |
| Operating Income | -5,612 | -3,008 | N/A | -5,924 | N/A |
| Interest Expense | 805 | 744 | 0 | 639 | 0 |
| Other Income | 82 | -94 | 0 | 6,426 | 0 |
| Pre-tax Income | -6,335 | -3,846 | 0 | -137 | 0 |
| Net Income Continuous | -6,335 | -3,846 | N/A | -137 | N/A |
| Net Income | $-6,335 | $-3,846 | $N/A | $-137 | $N/A |
| EPS Basic Total Ops | -2.60 | -1.60 | N/A | -2.50 | N/A |
| EPS Basic Continuous Ops | -2.62 | -1.59 | N/A | -0.06 | N/A |
| EPS Diluted Total Ops | -2.60 | -1.60 | N/A | -2.50 | N/A |
| EPS Diluted Continuous Ops | -2.62 | -1.59 | N/A | -0.06 | N/A |
| EBITDA(a) | $-5,595 | $-2,992 | $N/A | $-18 | $N/A |